A Neutrophil Extracellular Traps–Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, School of Medicine, Shanghai First Maternity and Infant Hospital, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Extracellular Traps, Ovarian Neoplasms, Gene Expression Regulation, Neoplastic, Neutrophils. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Ovarian cancer (OvCa) is the most lethal gynaecology malignancies worldwide. Neutrophil extracellular traps (NETs), net‐like protein structures produced by activated neutrophils and DNA‐histone complexes, have a central role in tumours, though haven't been fully explored in OvCa. We obtained transcriptome data from TCGA‐OvCa database ( n = 376) as training, ICGC‐OvCa database ( n = 111) as validation and GTEx database ( n = 180) as controls. Through LASSO‐COX Regression analysis, we identified an eight‐gene signature among 87 NETs‐related genes, which was significantly related to poor prognosis in both TCGA‐OvCa and ICGC‐OvCa cohorts (Log‐rank p ‐value = 0.0003 and 0.0014). Next, we constructed and validated a prognostic nomogram, consist of NETs‐related signature and clinical features (C‐index = 0.82). We evaluated 22 typical immune cell infiltration through CIBERSORT analysis, which implied upregulation of memory CD4 + T cells, follicular helper T cells and neutrophils in high‐risk group. Additionally, we predicted therapy sensitivity through TIDE algorithm, indicating that high NETs‐riskscore exhibited more sensitivity towards Sorafenib and less sensitivity towards immunotherapy. We initially reported that RAC2 upregulation was associated with NETs formation and poor prognosis ( p ‐value < 0.05) through IHC analysis of tissue microarrays ( n = 125). Conclusively, NETs‐related signature was reliable for OvCa prognosis prediction and therapy assessment. Especially, RAC2 was predominantly related to NETs formation, thus providing hints towards anti‐tumour mechanism of NETs in OvCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, School of Medicine, Shanghai First Maternity and Infant Hospital, Tongji University, Shanghai, China.
- Shanghai Key Laboratory of Maternal Fetal Medicine, School of Medicine, Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Tongji University, Shanghai,…
- Department of Obstetrics and Gynecology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, China.
ORCID-Profile: Yu Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhang, Y., Wang, C., Cheng, S., Xu, Y., Gu, S., Zhao, Y., Yang, J., & Wang, Y. (2024). A Neutrophil Extracellular Traps–Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70302
Vancouver
Zhang Y, Wang C, Cheng S, Xu Y, Gu S, Zhao Y, et al. A Neutrophil Extracellular Traps–Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70302
BibTeX
@article{Zhang2024,
author = {Zhang, Yue and Wang, Chao and Cheng, Shanshan and Xu, Yanna and Gu, Sijia and Zhao, Yaqian and Yang, Jiani and Wang, Yu},
title = {A Neutrophil Extracellular Traps–Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70302}
}
EUVIMED